These findings inspired us to explore the potential of fifty-nine isoflavonoids (1–59) (Figure 1) as a possible treatment for COVID-19 through in silico examination of their potential to bind with ACE-2 and Mpro receptors. Here, ACE2 is linked to COVID-19.